Cargando…
Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
Fibroblast activation protein (FAP), overexpressed on cancer-associated fibroblasts (CAFs), is a novel target for molecular imaging of various tumors. Recently, the development of several small-molecule FAP inhibitors for radiolabeling with (68)Ga has resulted in the emergence of studies evaluating...
Autores principales: | Kuyumcu, Serkan, Sanli, Yasemin, Subramaniam, Rathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632139/ https://www.ncbi.nlm.nih.gov/pubmed/34858834 http://dx.doi.org/10.3389/fonc.2021.758958 |
Ejemplares similares
-
(177)Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
por: Sanli, Yasemin, et al.
Publicado: (2021) -
The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
por: Dong, Yanzhao, et al.
Publicado: (2023) -
PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022) -
Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients
por: Rong, Xiaoxiang, et al.
Publicado: (2022) -
Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)